Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AT III in septicemia with DIC

H P Schuster1

  • 1Medizinische Klinik I, Städtisches Krankenhaus Hildesheim, Germany.

Intensive Care Medicine
|January 1, 1993
PubMed
Summary

Sepsis-related disseminated intravascular coagulation (DIC) is linked to Antithrombin III depletion. Antithrombin III substitution therapy may improve outcomes for septic patients with DIC.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Acute coronary syndrome without ST-elevation (NSTE-ACS)].

Herz·2019
Same author

[End-organ damage. ].

Der Internist·2003
Same author

[Innovative developments in geriatric medicine].

Der Internist·2002
Same author

[The historical development of intensive care in Germany. Contemporary views. 20. The limits of intensive care--economic and ethical limits] .

Der Anaesthesist·2001
Same author

[The history of the development of intensive care in Germany--contemporary reflections. 12. The development of intravenous infusion techniques from personal experience].

Der Anaesthesist·2000
Same author

[The history of the development of intensive care in Germany. 11. The development of parenteral nutrition].

Der Anaesthesist·2000

Area of Science:

  • Critical care medicine
  • Hematology
  • Pathophysiology of coagulation

Background:

  • Disseminated intravascular coagulation (DIC) is a frequent complication in sepsis.
  • Antithrombin III (ATIII) is a crucial serine protease inhibitor regulating clotting factors.
  • ATIII depletion is observed concurrently with DIC development in septic patients.

Purpose of the Study:

  • To investigate the link between ATIII depletion and sepsis-induced DIC.
  • To establish the rationale for ATIII substitution therapy in treating sepsis-related DIC.
  • To provide a basis for future clinical trials and research.

Main Methods:

  • Review of existing studies on sepsis, DIC, and ATIII levels.
  • Analysis of physiological and clinical findings.
  • Synthesis of evidence to support therapeutic hypotheses.

Main Results:

  • A strong correlation exists between DIC development and Antithrombin III depletion in sepsis.
  • Substitution therapy with ATIII is hypothesized to be beneficial.
  • Potential for improved outcomes in septic patients receiving ATIII therapy.

Conclusions:

  • Antithrombin III substitution therapy presents a promising strategy for managing sepsis-related DIC.
  • Further clinical trials are warranted to confirm the efficacy of ATIII therapy.
  • Understanding the role of ATIII is key to improving sepsis patient care.

Related Experiment Videos